GSK | Page 3 | The Business Standard

GSK buys 10% of CureVac in vaccine tech deal

GSK and CureVac, backed by Microsoft billionaire Bill Gates, will work on developing up to five so-called mRNA-based vaccines and monoclonal antibodies (mAbs) for infectious diseases

World+Biz

GSK says long-acting HIV prevention drug 65% more effective than Truvada

Coronavirus chronicle

GSK to work on potential Covid-19 shot with Canada's Medicago

File Photo: Small bottles labeled with a "Vaccine Covid-19" sticker and a medical syringe are seen in this illustration taken April 10, 2020. Reuters/Dado Ruvic/Illustration/File Photo

Coronavirus chronicle

Britain nears 500 million stg deal for Sanofi/GSK Covid-19 vaccine

Stocks

Unilever to buy GSK's shares in 30 days

Coronavirus chronicle

GSK tests experimental drug to treat pneumonia from Covid-19

Global Economy

Britain's GSK sells $3.35 billion stake in Hindustan Unilever

Corporates

GSK’s net profit increases by 35.44%

Thoughts

GSK partners with Care Bangladesh to support Covid-19 affected people

Global Economy